~~<i id='3AD9E6B123'><strike id='3AD9E6B123'><tt id='3AD9E6B123'><pre id='3AD9E6B123'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

explore

Wikipedia

author：Wikipedia 2025-09-28 00:51:05 - browse：69124

Ever since Medicare was given power to negotiate prices for certain medicines, the pharmaceutical industry has argued the move will end badly for patients.

Beyond complaining about price controls and unconstitutional mandates, the key message aimed at the American public has been that innovation will suffer.

This is a familiar but tiring refrain.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New air purifier tech could be key to improving indoor air quality
Next article： Orangutan used medicinal plant to treat wound, first time ever seen

explore

knowledge

entertainment

leisure time

entertainment

MelindaFrenchGateswillstepdownasco-chairoftheBill&MelindaGatesFoundation.ChristopheEna/APMelinda

WSS

Wearables generate powerful data but its not useful to doctors, yet

After traumatic brain injury, life support decisions can use more time

HIV vaccine remains elusive. Immunologists keep trying new ideas

MassMutual is introducing free genetic testing for members

It's time to retire 'poor historian' from clinicians' vocabularies

Criminal prosecution for violating HIPAA: an emerging threat

explore

Wikipedia

explore

Supreme Court strikes down use of affirmative action

Readers respond to H5N1 and livestock movements, and more

ChatGPT in medicine: STAT answers readers' burning questions

MassMutual is introducing free genetic testing for members

Walensky prepares to leave CDC — and Congress — behind

Big Tobacco's 'harm reduction': Is it for real, or a sham?

After affirmative action ruling, medical educators look to 'holistic review'

When prostate cancer spreads, where it goes matters

Activists slam private health insurers over coverage restrictions

BIO: Crackdown on China pharma industry would threaten U.S. drug supply

knowledge

Big Tobacco's 'harm reduction': Is it for real, or a sham?

More tobacco lobbyists active in statehouses

Readout LOUD podcast: Live from STAT Breakthrough Summit West

FTC falls short on scrutinizing hospital mergers, study says

Second House panel advances two

Anxious about a speech? A startup wants you to pop a minty cardiac drug

entertainment

leisure time

entertainment

entertainment